Inhibition of G6PD restores cisplatin sensitivity in ovarian cancer cells and enhances the sensitivity of colorectal cancer cells to oxaliplatin treatment (Catanzaro et al., 2015; Ju et al., 2017). The gene discussed is G6PD; the disease is colorectal cancer.